Α. Φωτίου

1.1k total citations
23 papers, 755 citations indexed

About

Α. Φωτίου is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Α. Φωτίου has authored 23 papers receiving a total of 755 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Oncology and 7 papers in Genetics. Recurrent topics in Α. Φωτίου's work include Cancer Treatment and Pharmacology (5 papers), Estrogen and related hormone effects (5 papers) and Virus-based gene therapy research (2 papers). Α. Φωτίου is often cited by papers focused on Cancer Treatment and Pharmacology (5 papers), Estrogen and related hormone effects (5 papers) and Virus-based gene therapy research (2 papers). Α. Φωτίου collaborates with scholars based in United Kingdom and United States. Α. Φωτίου's co-authors include Spyros Retsas, Alison J.‐A. Woolford, Simak Ali, R. Russell‐Jones, Eduardo Calonje, Guy Orchard, Sean Whittaker, Julia J. Inglis, Bruce Kidd and Helen M. I. Osborn and has published in prestigious journals such as Nature Medicine, Cancer Research and Oncogene.

In The Last Decade

Α. Φωτίου

23 papers receiving 727 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Α. Φωτίου United Kingdom	14	339	208	141	137	114	23	755
Katherine Drews‐Elger United States	13	514 1.5×	359 1.7×	78 0.6×	41 0.3×	147 1.3×	20	1.0k
Elżbieta Płuciennik Poland	19	604 1.8×	255 1.2×	71 0.5×	42 0.3×	58 0.5×	69	1.1k
Zi Wang China	17	585 1.7×	205 1.0×	91 0.6×	36 0.3×	42 0.4×	64	968
Prachi Bajpai United States	15	507 1.5×	98 0.5×	39 0.3×	41 0.3×	46 0.4×	34	754
Shilpak Chatterjee United States	18	254 0.7×	307 1.5×	92 0.7×	32 0.2×	148 1.3×	40	947
Irit Zurer Israel	10	590 1.7×	357 1.7×	102 0.7×	17 0.1×	42 0.4×	11	951
Hubert Kasperczyk Germany	9	474 1.4×	121 0.6×	43 0.3×	28 0.2×	55 0.5×	12	645
Levi Fried United States	12	408 1.2×	137 0.7×	42 0.3×	41 0.3×	83 0.7×	13	860
Majken Westergaard Denmark	11	708 2.1×	185 0.9×	26 0.2×	106 0.8×	58 0.5×	14	1.0k
Eun Ji Lee South Korea	15	552 1.6×	116 0.6×	53 0.4×	19 0.1×	93 0.8×	30	870

Countries citing papers authored by Α. Φωτίου

Since Specialization

Citations

This map shows the geographic impact of Α. Φωτίου's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Α. Φωτίου with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Α. Φωτίου more than expected).

Fields of papers citing papers by Α. Φωτίου

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Α. Φωτίου. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Α. Φωτίου. The network helps show where Α. Φωτίου may publish in the future.

Co-authorship network of co-authors of Α. Φωτίου

This figure shows the co-authorship network connecting the top 25 collaborators of Α. Φωτίου. A scholar is included among the top collaborators of Α. Φωτίου based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Α. Φωτίου. Α. Φωτίου is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Scott, Susan C., et al.. (2013). LATS2 is a modulator of estrogen receptor alpha.. PubMed. 33(1). 53–63. 16 indexed citations

Zhang, Hua, Α. Φωτίου, Arnhild Grothey, Justin Stebbing, & Georgios Giamas. (2012). The role of pseudokinases in cancer. Cellular Signalling. 24(6). 1173–1184. 28 indexed citations

Giamas, Georgios, Aleksandra Filipović, Jimmy Jacob, et al.. (2011). Kinome screening for regulators of the estrogen receptor identifies LMTK3 as a new therapeutic target in breast cancer. Nature Medicine. 17(6). 715–719. 105 indexed citations

Tolhurst, Robert S., Ross S. Thomas, Hetal Patel, et al.. (2010). Transient over-expression of estrogen receptor-α in breast cancer cells promotes cell survival and estrogen-independent growth. Breast Cancer Research and Treatment. 128(2). 357–368. 21 indexed citations

Thiruchelvam, Paul, Chun‐Fui Lai, Hui Hua, et al.. (2010). The liver receptor homolog-1 regulates estrogen receptor expression in breast cancer cells. Breast Cancer Research and Treatment. 127(2). 385–396. 61 indexed citations

Φωτίου, Α., et al.. (2009). Capsaicin-sensitive primary sensory neurons in the mouse express N-Acyl phosphatidylethanolamine phospholipase D. Neuroscience. 161(2). 572–577. 13 indexed citations

Stronach, Euan A., et al.. (2009). Microarray coupled to quantitative RT–PCR analysis of androgen-regulated genes in human LNCaP prostate cancer cells. Oncogene. 28(19). 2051–2063. 54 indexed citations

Kidd, Bruce, Α. Φωτίου, & Julia J. Inglis. (2004). The Role of Inflammatory Mediators on Nociception and Pain in Arthritis. Novartis Foundation symposium. 260. 122–138. 48 indexed citations

Scarisbrick, Julia, Alison J.‐A. Woolford, Eduardo Calonje, et al.. (2002). Frequent Abnormalities of the P15 and P16 Genes in Mycosis Fungoides and Sezary Syndrome. Journal of Investigative Dermatology. 118(3). 493–499. 74 indexed citations

10.

Jordan, Allan M., et al.. (2001). Melanocyte-Directed enzyme prodrug therapy (MDEPT). Bioorganic & Medicinal Chemistry. 9(6). 1549–1558. 41 indexed citations

11.

Child, Fiona, R. Russell‐Jones, Alison J.‐A. Woolford, et al.. (2001). Absence of the t(14;18) chromosomal translocation in primary cutaneous B-cell lymphoma. British Journal of Dermatology. 144(4). 735–744. 76 indexed citations

12.

Jordan, Allan M., Tariq H Khan, Helen M. I. Osborn, Α. Φωτίου, & Patrick A. Riley. (1999). Melanocyte-directed enzyme prodrug therapy (MDEPT): development of a targeted treatment for malignant melanoma. Bioorganic & Medicinal Chemistry. 7(9). 1775–1780. 39 indexed citations

13.

Φωτίου, Α., et al.. (1997). In vitro synergy of paclitaxel (Taxol) and vinorelbine (navelbine) against human melanoma cell lines. European Journal of Cancer. 33(3). 463–470. 71 indexed citations

14.

Φωτίου, Α.. (1997). In Vitro Synergy of Paclitaxel (Taxol) and Vinorelbine (Navelbine) Against Human Melanoma Cell Lines. European Journal of Cancer. 33(3). 463–470. 1 indexed citations

15.

Φωτίου, Α., et al.. (1996). The combination of paclitaxel with cisplatin exhibits antagonism in vitro against human melanoma. Anti-Cancer Drugs. 7(4). 493–498. 8 indexed citations

16.

Burke, P. J., et al.. (1996). Antibody-directed enzyme prodrug therapy (ADEPT). International Journal of Oncology. 9(3). 567–570. 9 indexed citations

17.

Houghton, P.J., et al.. (1994). Activity of Extracts ofKigelia pinnataAgainst Melanoma and Renal Carcinoma Cell Lines. Planta Medica. 60(5). 430–433. 47 indexed citations

18.

Tolis, C., et al.. (1993). Growth inhibitory activity of S12363, a novel vinca alkaloid derivative on human melanoma cell lines.. PubMed. 13(1). 161–6. 3 indexed citations

19.

Φωτίου, Α., et al.. (1992). Antiproliferative activity of vinorelbine (Navelbine) against six human melanoma cell lines. Journal of Cancer Research and Clinical Oncology. 118(4). 249–254. 20 indexed citations

20.

Nias, A.H.W., Paul Perry, & Α. Φωτίου. (1988). Modulating the Oxygen Tension in Tumours by Hypothermia and Hyperbaric Oxygen. Journal of the Royal Society of Medicine. 81(11). 633–636. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact